Respiratory Drugs Market Driven By Advanced Therapies

added blog Health

2026-07-22 08:51:19 - Translate -

The Respiratory Drugs Market growth continues to accelerate as idiopathic pulmonary fibrosis and interstitial lung diseases gain recognition and therapeutic options expand beyond historical nihilism. With IPF representing a progressive fatal disease affecting approximately 3 million people worldwide and antifibrotic therapies demonstrating slowed disease progression, the demand for pirfenidone,...

0 Comments 0 Shares 4 Views 0 Reviews